Have any questions? 706-721-6582 or cts@augusta.edu
The purpose of this research registry is to study the long-term safety of abatacept (Orencia©) and see what effects (good and bad) it has on your child and his/her JIA. Abatacept has already been approved by the FDA for treatment of Juvenile Idiopathic Arthritis (JIA).